FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial Has presentation strength numerator value False un Inferred relationship Some 1
    Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False un Inferred relationship Some 1
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Trastuzumab 150 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Trastuzumab 150 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Pentostatin 10 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Pentostatin 10 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False un Inferred relationship Some 1
    Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    méropenem 500 mg, fiole de poudre pour solution injectable Has presentation strength denominator value False un Inferred relationship Some 1
    méropenem 500 mg, fiole de poudre pour solution injectable Count of base of active ingredient False un Inferred relationship Some
    Hyaluronidase 1500 unit powder for solution for injection ampule Has presentation strength denominator value False un Inferred relationship Some 1
    Hyaluronidase 1500 unit powder for solution for injection ampule Count of base of active ingredient False un Inferred relationship Some
    Mitomycin 2 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Mitomycin 2 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Neomycin sulfate 25 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Infliximab 100 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Infliximab 100 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Imiglucerase 200 unit powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
    Imiglucerase 200 unit powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
    Gabapentin 50 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Chlorpromazine hydrochloride 5 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 2
    Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Has concentration strength numerator value False un Inferred relationship Some 1
    Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False un Inferred relationship Some
    Cimetidine 40 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Cimetidine 40 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Cefprozil 50 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Cefprozil 50 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Cefalexin 100 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Cefalexin 100 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Cefradine 50 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Cefradine 50 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Chloral hydrate 28.6 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
    Chloral hydrate 28.6 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Paracetamol 50 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
    Paracetamol 50 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely chloral hydrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely chloral hydrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely cefadroxil (as cefadroxil monohydrate) 50 milligram/1 milliliter conventional release oral suspension Has concentration strength denominator value False un Inferred relationship Some 1

    Start Previous Page 73 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start